← Leaderboards
Catherine A Burkhart
Cleveland Biolabs, Inc.
$980,747
Attributed
$980,747
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $397K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$980,747 · 3
By mechanism
R44$750,305 · 1
R43$230,442 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeNormal CellChildMalignant NeoplasmsNeoplastic CellScreening ProcedureDrug ResistanceHigh Throughput ScreeningLeadLibrariesBiologicalNeuroblastomaPharmaceutical PreparationsPlayInhibitor/AntagonistDrug DevelopmentEvaluationGrowthIn VivoCell ProliferationCellsBaseMediatingSmall Molecule Libraries
Grant awards (4)
Targeting MLL As Anticancer Therapy for Infant Acute Lymphoblastic Leukemia$130,694
R43 · FY2009 · CA · contact PI
N-myc Targeted Therapeutics for Childhood Neuroblastoma$396,999
R44 · FY2007 · CA · contact PI
N-myc Targeted Therapeutics for Childhood Neuroblastoma$353,306
R44 · FY2006 · CA · contact PI
N-myc Targeted Therapeutics for Childhood Neuroblastoma$99,748
R43 · FY2004 · CA